{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:00:30Z","timestamp":1793833230672,"version":"4.6.1"},"reference-count":37,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,7,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Interactions within the hematopoietic niche in the BM microenvironment are essential for maintenance of the stem cell pool. In addition, this niche is thought to serve as a sanctuary site for malignant progenitors during chemotherapy. Therapy resistance induced by interactions with the BM microenvironment is a major drawback in the treatment of hematologic malignancies and bone-metastasizing solid tumors. To date, studying these interactions was hampered by the lack of adequate in vivo models that simulate the human situation. In the present study, we describe a unique human-mouse hybrid model that allows engraftment and outgrowth of normal and malignant hematopoietic progenitors by implementing a technology for generating a human bone environment. Using luciferase gene marking of patient-derived multiple myeloma cells and bioluminescent imaging, we were able to follow pMM cells outgrowth and to visualize the effect of treatment. Therapeutic interventions in this model resulted in equivalent drug responses as observed in the corresponding patients. This novel human-mouse hybrid model creates unprecedented opportunities to investigate species-specific microenvironmental influences on normal and malignant hematopoietic development, and to develop and personalize cancer treatment strategies.<\/jats:p>","DOI":"10.1182\/blood-2012-03-414920","type":"journal-article","created":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:58:26Z","timestamp":1338512306000},"page":"e9-e16","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":109,"title":["Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma"],"prefix":"10.1182","volume":"120","author":[{"given":"Richard W. J.","family":"Groen","sequence":"first","affiliation":[{"name":"Departments of Cell Biology,"},{"name":"Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willy A.","family":"Noort","sequence":"additional","affiliation":[{"name":"Departments of Cell Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinier A.","family":"Raymakers","sequence":"additional","affiliation":[{"name":"Hematology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk-Jan","family":"Prins","sequence":"additional","affiliation":[{"name":"Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Aalders","sequence":"additional","affiliation":[{"name":"Departments of Cell Biology,"},{"name":"Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans M.","family":"Hofhuis","sequence":"additional","affiliation":[{"name":"Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Moerer","sequence":"additional","affiliation":[{"name":"Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen F.","family":"van Velzen","sequence":"additional","affiliation":[{"name":"Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andries C.","family":"Bloem","sequence":"additional","affiliation":[{"name":"Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berris","family":"van Kessel","sequence":"additional","affiliation":[{"name":"Clinical Chemistry and Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"Rozemuller","sequence":"additional","affiliation":[{"name":"Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"van Binsbergen","sequence":"additional","affiliation":[{"name":"Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan","family":"Buijs","sequence":"additional","affiliation":[{"name":"Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huipin","family":"Yuan","sequence":"additional","affiliation":[{"name":"Xpand Biotechnology BV, Bilthoven, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost D.","family":"de Bruijn","sequence":"additional","affiliation":[{"name":"Xpand Biotechnology BV, Bilthoven, The Netherlands;"},{"name":"The School of Engineering and Materials Science, Queen Mary University of London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"de Weers","sequence":"additional","affiliation":[{"name":"Genmab, Utrecht, The Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W. H. I.","family":"Parren","sequence":"additional","affiliation":[{"name":"Genmab, Utrecht, The Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Jacob","family":"Schuringa","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk M.","family":"Lokhorst","sequence":"additional","affiliation":[{"name":"Hematology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuna","family":"Mutis","sequence":"additional","affiliation":[{"name":"Clinical Chemistry and Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton C. M.","family":"Martens","sequence":"additional","affiliation":[{"name":"Departments of Cell Biology,"},{"name":"Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2019111807572413700_B1","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI28568","article-title":"The stem cell niches in bone.","volume":"116","author":"Yin","year":"2006","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111807572413700_B2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nri2279","article-title":"Uncertainty in the niches that maintain haematopoietic stem cells.","volume":"8","author":"Kiel","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"2019111807572413700_B3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/stem.453","article-title":"Concise review: multiple niches for hematopoietic stem cell regulations.","volume":"28","author":"Oh","year":"2010","journal-title":"Stem cells"},{"issue":"20","key":"2019111807572413700_B4","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1182\/blood-2011-01-315069","article-title":"Bone and the hematopoietic niche: a tale of two stem cells.","volume":"117","author":"Bianco","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2019111807572413700_B5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"8","key":"2019111807572413700_B6","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.yexcr.2010.02.045","article-title":"Hallmarks of cancer: interactions with the tumor stroma.","volume":"316","author":"Pietras","year":"2010","journal-title":"Exp Cell Res"},{"issue":"1","key":"2019111807572413700_B7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MOP.0b013e3283426260","article-title":"How new advances in genetic analysis are influencing the understanding and treatment of childhood acute leukemia.","volume":"23","author":"Roberts","year":"2011","journal-title":"Curr Opin Pediatr"},{"issue":"6","key":"2019111807572413700_B8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(02)00211-8","article-title":"Acute leukemia: a pediatric perspective.","volume":"2","author":"Downing","year":"2002","journal-title":"Cancer Cell"},{"issue":"20","key":"2019111807572413700_B9","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2010.32.8500","article-title":"Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system.","volume":"29","author":"R\u00f6llig","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"2019111807572413700_B10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/leu.2008.48","article-title":"The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites.","volume":"22","author":"Shiozawa","year":"2008","journal-title":"Leukemia"},{"issue":"6","key":"2019111807572413700_B11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood-2009-01-202606","article-title":"The leukemic stem cell niche: current concepts and therapeutic opportunities.","volume":"114","author":"Lane","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2019111807572413700_B12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1200\/JCO.2010.31.0904","article-title":"Leukemia stem cells and microenvironment: biology and therapeutic targeting.","volume":"29","author":"Konopleva","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111807572413700_B13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12307-009-0034-7","article-title":"The hemopoietic stem cell niche versus the microenvironment of the multiple myeloma-tumor initiating cell.","volume":"3","author":"Zipori","year":"2010","journal-title":"Cancer Microenviron"},{"issue":"4","key":"2019111807572413700_B14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MOH.0b013e32833a25d8","article-title":"Stem cell regulatory niches and their role in normal and malignant hematopoiesis.","volume":"17","author":"Carlesso","year":"2010","journal-title":"Curr Opin Hematol"},{"issue":"12","key":"2019111807572413700_B15","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/leu.2010.214","article-title":"The endosteal \u2018osteoblastic\u2019 niche and its role in hematopoietic stem cell homing and mobilization.","volume":"24","author":"L\u00e9vesque","year":"2010","journal-title":"Leukemia"},{"issue":"1","key":"2019111807572413700_B16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI41158","article-title":"Enabling stem cell therapies through synthetic stem cell-niche engineering.","volume":"120","author":"Peerani","year":"2010","journal-title":"J Clin Invest"},{"issue":"12","key":"2019111807572413700_B17","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1089\/ten.tea.2008.0666","article-title":"Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum.","volume":"15","author":"Prins","year":"2009","journal-title":"Tissue Eng Part A"},{"issue":"11","key":"2019111807572413700_B18","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1089\/ten.tea.2009.0774","article-title":"Luciferase labeling for multipotent stromal cell tracking in spinal fusion versus ectopic bone tissue engineering in mice and rats.","volume":"16","author":"Geuze","year":"2010","journal-title":"Tissue Eng Part A"},{"issue":"3","key":"2019111807572413700_B19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1182\/blood-2009-02-204396","article-title":"Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma.","volume":"115","author":"Reijmers","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111807572413700_B20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2008.01.007","article-title":"AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies.","volume":"13","author":"Chesi","year":"2008","journal-title":"Cancer Cell"},{"issue":"11","key":"2019111807572413700_B21","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ejca.2005.12.025","article-title":"The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors, their receptors and stromal interactions.","volume":"42","author":"Mitsiades","year":"2006","journal-title":"Eur J Cancer"},{"issue":"8","key":"2019111807572413700_B22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrc2189","article-title":"Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets.","volume":"7","author":"Hideshima","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2019111807572413700_B23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/leu.2008.259","article-title":"Bone marrow microenvironment and the identification of new targets for myeloma therapy.","volume":"23","author":"Podar","year":"2009","journal-title":"Leukemia"},{"issue":"3","key":"2019111807572413700_B24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2007.10.024","article-title":"Limiting the proliferation of polyploid cells.","volume":"131","author":"Ganem","year":"2007","journal-title":"Cell"},{"issue":"4","key":"2019111807572413700_B25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.molonc.2011.07.007","article-title":"p53: Guardian of ploidy.","volume":"5","author":"Aylon","year":"2011","journal-title":"Mol Oncol"},{"issue":"13","key":"2019111807572413700_B26","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1182\/blood-2006-05-026112","article-title":"Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition.","volume":"108","author":"Giuliani","year":"2006","journal-title":"Blood"},{"issue":"6","key":"2019111807572413700_B27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bone.2008.01.027","article-title":"The pathogenesis of the bone disease of multiple myeloma.","volume":"42","author":"Edwards","year":"2008","journal-title":"Bone"},{"issue":"2","key":"2019111807572413700_B28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jcb.22403","article-title":"Pathogenesis of myeloma bone disease.","volume":"109","author":"Roodman","year":"2010","journal-title":"J Cell Biochem"},{"issue":"2","key":"2019111807572413700_B29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/10428190903503438","article-title":"Osteoblastogenesis and tumor growth in myeloma.","volume":"51","author":"Yaccoby","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"2019111807572413700_B30","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3324\/haematol.12349","article-title":"A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect.","volume":"93","author":"Rozemuller","year":"2008","journal-title":"Haematologica"},{"issue":"3","key":"2019111807572413700_B31","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.1003032","article-title":"Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.","volume":"186","author":"de Weers","year":"2011","journal-title":"J Immunol"},{"issue":"7","key":"2019111807572413700_B32","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3324\/haematol.2010.028035","article-title":"Niche contributions to oncogenesis: emerging concepts and implications for the hematopoietic system.","volume":"96","author":"Raaijmakers","year":"2011","journal-title":"Haematologica"},{"issue":"1","key":"2019111807572413700_B33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1203\/PDR.0b013e3181e1cfce","article-title":"Hematopoiesis in regenerated bone marrow within hydroxyapatite scaffold.","volume":"68","author":"Fujita","year":"2010","journal-title":"Pediatr Res"},{"issue":"2","key":"2019111807572413700_B34","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V90.2.754","article-title":"The development of a model for the homing of multiple myeloma cells to human bone marrow.","volume":"90","author":"Urashima","year":"1997","journal-title":"Blood"},{"issue":"8","key":"2019111807572413700_B35","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood.V92.8.2908","article-title":"Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations.","volume":"92","author":"Yaccoby","year":"1998","journal-title":"Blood"},{"issue":"11","key":"2019111807572413700_B36","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/sj.leu.2403513","article-title":"The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells.","volume":"18","author":"Yata","year":"2004","journal-title":"Leukemia"},{"issue":"4","key":"2019111807572413700_B37","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/leu.2010.300","article-title":"A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells.","volume":"25","author":"Calimeri","year":"2011","journal-title":"Leukemia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/3\/e9\/1361963\/zh8029120000e9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/3\/e9\/1361963\/zh8029120000e9.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T18:18:46Z","timestamp":1713982726000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/3\/e9\/30465\/Reconstructing-the-human-hematopoietic-niche-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,19]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,7,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-03-414920","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.716697810.792003170","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,19]]}}}